IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

OTTRIA, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.276
NA - Nord America 4.198
AS - Asia 3.818
SA - Sud America 290
AF - Africa 76
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.686
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.063
CN - Cina 1.228
SG - Singapore 1.134
IT - Italia 1.081
GB - Regno Unito 989
RU - Federazione Russa 478
SE - Svezia 429
DE - Germania 326
HK - Hong Kong 299
BD - Bangladesh 226
BR - Brasile 207
IN - India 199
NL - Olanda 189
VN - Vietnam 184
FR - Francia 173
JP - Giappone 127
KR - Corea 117
TR - Turchia 111
FI - Finlandia 107
DK - Danimarca 88
IE - Irlanda 84
CA - Canada 82
UA - Ucraina 81
ID - Indonesia 60
ES - Italia 53
PL - Polonia 45
EU - Europa 31
CH - Svizzera 28
CO - Colombia 26
MX - Messico 26
AR - Argentina 23
BE - Belgio 23
AU - Australia 22
TW - Taiwan 20
CI - Costa d'Avorio 18
GR - Grecia 16
ZA - Sudafrica 13
AT - Austria 12
CZ - Repubblica Ceca 12
UZ - Uzbekistan 12
PT - Portogallo 10
AZ - Azerbaigian 9
CL - Cile 9
SA - Arabia Saudita 9
VE - Venezuela 9
IQ - Iraq 8
RO - Romania 8
SC - Seychelles 8
EG - Egitto 7
IL - Israele 7
IR - Iran 7
LK - Sri Lanka 7
MY - Malesia 7
PH - Filippine 7
MA - Marocco 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
EC - Ecuador 5
HN - Honduras 5
HR - Croazia 5
JM - Giamaica 5
LT - Lituania 5
LU - Lussemburgo 5
PK - Pakistan 5
BY - Bielorussia 4
DZ - Algeria 4
KZ - Kazakistan 4
TH - Thailandia 4
TN - Tunisia 4
AO - Angola 3
BO - Bolivia 3
BW - Botswana 3
CR - Costa Rica 3
HU - Ungheria 3
JO - Giordania 3
LV - Lettonia 3
NI - Nicaragua 3
NO - Norvegia 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
SI - Slovenia 3
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
KE - Kenya 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MM - Myanmar 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BM - Bermuda 1
Totale 12.697
Salva come PNG Salva come JPEG
Città #
Southend 879
Singapore 684
Milan 432
Ashburn 406
Hong Kong 273
Chandler 260
San Jose 258
Beijing 219
Dallas 198
Seattle 155
Fairfield 138
Santa Clara 138
Wilmington 135
Council Bluffs 130
Los Angeles 124
Moscow 120
Dearborn 116
Ann Arbor 110
Princeton 103
Dublin 83
Boardman 80
Hefei 78
Houston 78
Redwood City 70
Woodbridge 66
New York 65
Bengaluru 63
Nanjing 61
Tokyo 60
Lauterbourg 54
Mountain View 54
Ho Chi Minh City 51
Frankfurt am Main 50
Shanghai 49
Munich 48
Cambridge 47
Buffalo 45
Helsinki 44
Jinan 44
Jakarta 43
Guangzhou 42
Hanoi 42
Seoul 40
Phoenix 36
Redmond 36
Jacksonville 35
Warsaw 33
Shenyang 31
Rome 30
Toronto 28
Hangzhou 26
Des Moines 24
Sakarya 24
Somerville 24
Berlin 22
Hebei 21
Amsterdam 20
Andover 19
Bogotá 19
Istanbul 19
Naples 19
Stockholm 19
Abidjan 18
Bodio Lomnago 18
Brussels 18
Changsha 18
Chicago 18
London 18
Serra 18
São Paulo 18
Turku 18
Falls Church 17
Orem 17
Turin 17
Wuhan 17
Zhengzhou 17
Nanchang 16
Nuremberg 16
Athens 15
Cangzhou 15
Columbus 15
The Dalles 15
Tianjin 15
Fuzhou 14
San Diego 14
Mumbai 13
Taipei 13
Da Nang 12
Eitensheim 12
Fremont 12
Silver Spring 12
Boston 11
Groningen 11
Montreal 11
Philadelphia 11
Washington 11
Bologna 10
Florence 10
Jiaxing 10
Pisa 10
Totale 7.271
Salva come PNG Salva come JPEG
Nome #
LC-MS/MS method development for quantification of doxorubicin and its metabolite 13-hydroxy doxorubicin in mice biological matrices : Application to a pharmaco-delivery study 1.125
A Glycomimetic Compound Inhibits DC-SIGN Mediated HIV Infection in Cellular and Cervical Explant Models 440
Small-Molecules as Chemiluminescent Probes to Detect Lipase Activity 398
Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model 355
Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines 352
H-Ferritin-nanocaged olaparib : a promising choice for both BRCA-mutated and sporadic triple negative breast cancer 331
Quantitative Characterization of Olaparib in Nanodelivery System and Target Cell Compartments by LC-MS/MS 307
Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage 297
Set-up and validation of a high throughput screening method for human monoacylglycerol lipase (MAGL) based on a new red fluorescent probe 295
Quantitative Lipidomic Analysis of Osteosarcoma Cell-Derived Products by {UHPLC}-{MS}/{MS} 284
17alpha- and 17beta-boldenone 17-glucuronides : synthesis and complete characterization by 1H and 13C NMR 274
Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase 256
Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signaling 252
A New Ultrasensitive Bioluminescence-Based Method for Assaying Monoacylglycerol Lipase 248
Chios Mastic Gum: Chemical Profile and Pharmacological Properties in Inflammatory Bowel Disease: From the Past to the Future 235
Clarifying the Use of Benzylidene Protecting Group for D-($mathplus$)-Ribono-1,4-Lactone, an Essential Building Block in the Synthesis of C-Nucleosides 232
Synthesis and evaluation of in vitro anticancer activity of some novel isopentenyladenosine derivatives 227
Effects of cytokinins, cytokinin ribosides and their analogs on the viability of normal and neoplastic human cells 226
Olaparib nanoformulation in H-ferritin as a promising option for both BRCA-mutated and sporadic triple negative breast cancer: An in vitro study 223
Plasma endocannabinoid behaviour in total knee and hip arthroplasty 221
Simultaneous ultra-high performance liquid chromathograpy-electrospray ionization-quadrupole-time of flight mass spectrometry quantification of endogenous anandamide and related N-acylethanolamides in bio-matrices 218
Novel Isopentenyladenosine analogues: synthesis and evaluation of antiproliferative activity 216
1H, 13C and 15N NMR spectral assignments of adenosine derivatives with different amino substituents at C6-position. 215
N-6-Alkyladenosines: synthesis and evaluation of in vitro anticancer activity 214
Sintesi e attività biologica di aciclonucleosidi analoghi dell’isopenteniladenosina potenzialmente dotati di attività biologica 209
Pseudosaccharides Functionalized Dendrons Inhibitors of MBL Are Able to Prevent Ischemic Injury In Mice 208
H-1, C-13 and N-15 NMR assignments for N-6-isopentenyladenosine/inosine analogues 205
Lipids and lipid signaling molecules in human milk and infant formula, a chemical characterization of relevant biochemical components 204
Synthesis of Differently Protected 1-C-Methyl-Ribofuranoses Intermediates for the Preparation of Biologically Active 1'-C-Methyl-Ribonucleosides 203
2-Arachidonoylglycerol Synthesis: Facile and Handy Enzymatic Method That Allows to Avoid Isomerization 200
Effects of N6-isopentenyladenosine and Analogues on Bladder Cancer 196
Synthesis of multivalent pseudo-mannosides as inhibitors of Mannose Binding Lectin, a potential target in human stroke 196
Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia 189
N6-Isopentenyladenosine and its Analogue N6-Benzyladenosine Induce Cell Cycle Arrest and Apoptosis in Bladder Carcinoma T24 Cells 186
Mass quantification of anandamide and related N-acylethanolamides in plasma for clinical investigations 183
Isopentenyladenosine analogues as potential antitumor agents : synthesis and structure-activity relationships 182
Novel Isopentenyladenosine Analogues : Synthesis, Characterization, and Evaluation of Antiproliferative Activity on Bladder Carcinoma Cells 181
Simple Synthesis of 17-β-O-hemisuccinate of Stanozolol for Immunoanalytical Methods 181
Serum endocannabinoids in assessing pain in patients with chronic pancreatitis and in those with pancreatic ductal adenocarcinoma 180
Lipid peroxidation inhibition study: A promising case of 1,3-di([1,1′-biphenyl]-3-yl)urea 179
Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer 179
Studies on the synthesis and the biological activity of nucleosides analogues related to isopentenyladenosine 178
Effects of bioactive fatty acid amide derivatives in zebrafish scale model of bone metabolism and disease 176
Placental Bioenergetics and Antioxidant Homeostasis in Maternal Obesity and Gestational Diabetes 169
N6-isopentenyladenosine a new potential anti-angiogenic compound that targets human microvascular endothelial cells in vitro 162
Tracing zinc’s role in preterm infants’ health: A narrative review 159
Design, synthesis, and biological evaluation of novel N6-Isopentenyladenosine Analogues 156
Gene expression profile modulation by the antitumor agent N6-isopentenyladenosine and characterization of its analogues 154
Mannose binding lectin as a target for cerebral ischemic injury 153
1H, 13C and 15N NMR assignments for N- and O-acylethanolamines, important family of naturally occurring bioactive lipid mediators 151
Reply to B Stansfield 150
Optimized synthesis and characterization of N-acylethanolamines and O-acylethanolamines, important family of lipid-signalling molecules 144
Studies on the synthesis and the biological activity of acyclonucleosides related to isopentenyladenosine 143
Pharmacogenomics and analogues of the antitumor agent N6-isopentenyladenosine 140
Fluorescence-Based Enzyme Activity Assay: Ascertaining the Activity and Inhibition of Endocannabinoid Hydrolytic Enzymes 130
Pre- to Postbiotics: The Beneficial Roles of Pediatric Dysbiosis Associated with Inflammatory Bowel Diseases 123
Discovery of MAGL Inhibition by Lophine Derivatives: An Unexpected Finding from Chemiluminescent Assay Development 117
Gut Microbiota-Derived Short-Chain Fatty Acids in Inflammatory Bowel Disease: Mechanistic Insights into Gut Inflammation, Barrier Function, and Therapeutic Potential 48
Totale 13.155
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.811
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022827 66 48 33 67 81 71 70 50 69 61 73 138
2022/2023978 152 107 84 105 114 154 27 69 87 15 46 18
2023/2024659 23 47 79 43 116 68 32 49 32 54 43 73
2024/20252.108 103 201 58 173 164 106 117 187 123 229 210 437
2025/20264.150 347 315 452 350 379 225 459 175 458 288 390 312
2026/202718 18 0 0 0 0 0 0 0 0 0 0 0
Totale 13.155